Abstract
The role of cytochrome b5 (b5) in the α-naphthoflavone (α-NF)-mediated inhibition of H2O2-supported 7-benzyloxyquinoline (7-BQ) debenzylation by heterologously expressed and purified cytochrome P450 3A4 (CYP3A4) was studied. Although α-NF showed negligible effect in an NADPH-dependent reconstituted system, inhibition of 7-BQ oxidation was observed in the H2O2 system. Analysis of the effect of various constituents of a standard reconstituted system on H2O2-supported activity showed that b5 alone resulted in a 2.5-fold increase in the kcat value and reversed the inhibitory effect of α-NF. In addition, titration with b5 suggested that only 65% of the CYP3A4 participated in the interaction with b5, consistent with cytochrome P450 (P450) heterogeneity. Study of the influence of b5 on the kinetics of H2O2-dependent destruction of the P450 heme moiety suggested two distinct conformers of CYP3A4 with different sensitivity to heme loss. In the absence of b5, 66% of the wild-type enzyme was bleached in the fast phase, whereas the addition of b5 decreased the fraction of the fast phase to 16%. Finally, to locate amino acid residues that might influence b5 action, several active site mutants were tested. Substitution of Ser-119, Ile-301, Ala-305, Ile-369, or Ala-370 with the larger Phe or Trp decreased or even abolished the activation by b5. Ser-119 is in the B′-C loop, a predicted b5-P450 interaction site, and Ile-301 and Ala-305 are closest to the heme. In conclusion, the interaction of b5 with P450 apparently leads to a conformational transition, which results in redistribution of the CYP3A4 pool.
Footnotes
-
This work was supported by National Institutes of Health Grant GM54995 and Center Grant ES06676.
-
Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.
-
doi:10.1124/dmd.105.004606.
-
ABBREVIATIONS: α-NF, α-naphthoflavone; P450, cytochrome P450; 7-BQ, 7-benzyloxyquinoline; 7-BFC, 7-benzyloxy-4-(trifluoromethyl)coumarin; 7-EFC, 7-ethoxy-4-(trifluoromethyl)coumarin; SRS, substrate recognition site; CPR, NADPH-cytochrome P450 reductase; b5, cytochrome b5; H2O2, hydrogen peroxide; CuOOH, cumene hydroperoxide; P450eryF, 6-deoxyerythronolide B hydroxylase; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; DOPC, dioleoylphosphatidylcholine.
- Received March 2, 2005.
- Accepted April 29, 2005.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|